Associate Professor of Surgery University of Texas Southwestern Dallas, Texas
Disclosure(s):
Vanessa Nomellini, MD, PhD: No relevant financial relationship(s) to disclose.
The use of flow cytometric testing, ELISpot, Nanostring, single cell RNAseq, Cytof, Somascan to endotype patients with sepsis as a prelude for deployment of targeted therapies will be discussed.
